drugset / Trial / NCT02176837

Intravenous Nitrite Infusion for Reversal of Cerebral Vasospasm After Subarachnoid Hemorrhage

NCT02176837

Phase 2 Terminated 6 enrolled Hope Pharmaceuticals
NaSingle-groupOpen-labelTreatment

Summary

The hypothesis is that intravenous infusion of sodium nitrite is safe and effective for the reversal of cerebral vasospasm after subarachnoid hemorrhage in patients with a cerebral aneurysm.

Timeline

Start
2014-06
Primary completion
2017-01-15
Completion
2017-01-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Nitrite Small molecule 0.1325 mg/kg Intravenous